World's Best Scientists 2026 revealed!
Jean-Yves Pierga

Jean-Yves Pierga

D-Index & Metrics

Medicine

D-Index
82
Citations
26839
World Ranking
16037
National Ranking
524

Overview

Jean-Yves Pierga is affiliated with the Institute Curie in France and has a substantial body of work primarily focused on oncology and cancer research. Their work spans multiple topics within medicine, biochemistry, genetics, and molecular biology, with a significant emphasis on breast cancer treatment and advanced breast cancer therapies.

The scientist's research covers several main topics including:

  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Cancer Genomics and Diagnostics
  • Cancer Treatment and Pharmacology
  • Cancer Cells and Metastasis
  • Cancer Immunotherapy and Biomarkers

The main fields of study for Jean-Yves Pierga involve:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these fields, subfields include:

  • Oncology
  • Cancer Research
  • Pulmonary and Respiratory Medicine
  • Genetics
  • Molecular Biology

Frequent co-authors in their research collaborations are:

  • François-Clément Bidard
  • Delphine Loirat
  • Enora Laas
  • Luc Cabel
  • Frédérique Berger

Publications have appeared regularly in venues such as:

  • Cancer Research
  • Cancers
  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Cancer Research

Representative recent papers by Jean-Yves Pierga include:

  • Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer, 2022, New England Journal of Medicine
  • 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age, 2021, The Lancet Oncology
  • Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial, 2022, The Lancet Oncology
  • Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer, 2024, New England Journal of Medicine
  • Clinical utility of circulating tumor cells: an update, 2020, Molecular Oncology

Best Publications

  • 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

    F. Cardoso;A. Costa;E. Senkus;M. Aapro

  • 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

    Fatima Cardoso;Laura J. van’t Veer;Jan Bogaerts;Leen Slaets

  • A pooled analysis of bone marrow micrometastasis in breast cancer

    Stephan Braun;Florian D. Vogl;Bjørn Naume;Wolfgang Janni

  • Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

    François-Clément Bidard;François-Clément Bidard;Dieter Peeters;Tanja Fehm;Franco Nolé

  • Lapatinib Plus Capecitabine in Patients With Previously Untreated Brain Metastases From HER2-positive Metastatic Breast Cancer (LANDSCAPE): A Single-Group Phase 2 Study

    Thomas Bachelot;Gilles Romieu;Mario Campone;Véronique Diéras

  • Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006

    M. Kaufmann;G. Von minckwitz;H. D. Bear;Aman U Buzdar

  • 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial

    Xavier Pivot;Gilles Romieu;Marc Debled;Jean-Yves Pierga

  • Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays

    Antoine Emmanuel Saliba;Laure Saias;Eleni Psychari;Nicolas Minc

  • Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer

    Wolfgang J. Janni;Brigitte Rack;Leon W.M.M. Terstappen;Jean Yves Pierga

  • Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial

    Jean-Yves Pierga;François-Clément Bidard;Claire Mathiot;Etienne Brain

  • Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients

    Jean-Yves Pierga;Charlyne Bonneton;Anne Vincent-Salomon;Patricia de Cremoux

  • Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.

    François-Clément Bidard;Stefan Michiels;Sabine Riethdorf;Volkmar Mueller

  • 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer

    Kevin Kalinsky;William E. Barlow;Julie R. Gralow;Funda Meric-Bernstam

  • Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

    François Clément Bidard;François Clément Bidard;Tanja Fehm;Michail Ignatiadis;Jeffrey B. Smerage

  • Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types

    Ronald Lebofsky;Charles Decraene;Virginie Bernard;Maud Kamal

  • The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

    Massimo Cristofanilli;Jean Yves Pierga;James Reuben;Alfred Rademaker

  • 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age

    Martine Piccart;Laura J. van 't Veer;Coralie Poncet;Josephine M.N. Lopes Cardozo

  • Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study

    L. Cabel;F. Riva;V. Servois;A. Livartowski

  • High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients

    J.-Y. Pierga;J.-Y. Pierga;D. Hajage;T. Bachelot;S. Delaloge

  • Single Circulating Tumor Cell Detection and Overall Survival in Non Metastatic Breast Cancer.

    F. Bidard;C. Mathiot;F. Mefti;S. Delaloge

Frequent Co-Authors

Véronique Diéras
Véronique Diéras Institute Curie
Suzette Delaloge
Suzette Delaloge Institut Gustave Roussy
Anne Vincent-Salomon
Anne Vincent-Salomon Institute Curie
Alain Fourquet
Alain Fourquet Institute Curie
Bernard Asselain
Bernard Asselain Institute Curie
Olivier Lantz
Olivier Lantz Institute Curie
Ivan Bièche
Ivan Bièche Institute Curie
Fabrice Andre
Fabrice Andre Institut Gustave Roussy
Xavier Sastre-Garau
Xavier Sastre-Garau Institute Curie
Mario Campone
Mario Campone Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to a variety of rewarding healthcare roles beyond traditional MD programs. Many students now pursue online graduate degrees to specialize and advance their careers while maintaining flexibility.

For instance, if you’re interested in mental health, check out online psych np programs. These programs offer a direct route to becoming a Psychiatric Mental Health Nurse Practitioner, a highly in-demand role in healthcare.

Administrative roles are also growing quickly in healthcare. You can consider enrolling in one of the cheapest mha programs online to gain skills in leadership, policy, and operations.

It’s important to evaluate the mha degree cost as you plan your investments in education. This helps you make informed decisions about affordability and return on investment.

For nursing professionals seeking top credentials, pursuing the cheapest dnp (Doctor of Nursing Practice) online can lead to advanced clinical, leadership, or academic positions.

Best Scientists Citing Jean-Yves Pierga

Trending Scientists